Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Khot

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|August 2, 2023
Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in <i>TP53</i>-mutated diseaseThomas E Lew, Edward R Scheffer Cliff, Michael Dickinson, et al.
Clinical Genitourinary Cancer|November 3, 2024
Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell CancerJane McKenzie, Ciara Conduit, Melissa Ng Liet Hing, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2012
A risk-adapted protocol for delayed administration of filgrastim after high-dose chemotherapy and autologous stem cell transplantationAmit Khot, Michael Dickinson, Kerrie Stokes, et al.
Internal Medicine Journal|August 27, 2021
Cytomegalovirus DNAemia and disease: current-era epidemiology, clinical characteristics and outcomes in cancer patients other than allogeneic haemopoietic transplantationKim H Tay, Monica A Slavin, Karin A Thursky, et al.
The Lancet. Haematology|February 1, 2023
Treatment approaches for patients with TP53-mutated mantle cell lymphomaThomas E Lew, Adrian Minson, Michael Dickinson, et al.
Bone Marrow Transplantation|August 26, 2022
Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoidesJessica Elliott, Shalini Ahlawat, H Miles Prince, et al.
Open Forum Infectious Diseases|October 23, 2023
High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post-Autologous Stem Cell Transplant PeriodVictoria G Hall, Natalie R Saunders, Emily Klimevski, et al.
Leukemia & Lymphoma|August 26, 2016
Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvementKah-Lok Chan, Carrie van der Weyden, Christine Khoo, et al.
BMC Cancer|November 4, 2025
Protocol for Fit4Transplant: iterative optimisation of an exercise prehabilitation service for haematological cancer patients using phase II adaptive trials and co-designCamille E Short, Lara Edbrooke, Shaza Abo, et al.
Haematologica|August 21, 2020
Clonal independence of <i>JAK2</i> and <i>CALR</i> or <i>MPL</i> mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencingElla R Thompson, Tamia Nguyen, Yamuna Kankanige, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|August 2, 2023
Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in <i>TP53</i>-mutated diseaseThomas E Lew, Edward R Scheffer Cliff, Michael Dickinson, et al.
Clinical Genitourinary Cancer|November 3, 2024
Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell CancerJane McKenzie, Ciara Conduit, Melissa Ng Liet Hing, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2012
A risk-adapted protocol for delayed administration of filgrastim after high-dose chemotherapy and autologous stem cell transplantationAmit Khot, Michael Dickinson, Kerrie Stokes, et al.
Internal Medicine Journal|August 27, 2021
Cytomegalovirus DNAemia and disease: current-era epidemiology, clinical characteristics and outcomes in cancer patients other than allogeneic haemopoietic transplantationKim H Tay, Monica A Slavin, Karin A Thursky, et al.
The Lancet. Haematology|February 1, 2023
Treatment approaches for patients with TP53-mutated mantle cell lymphomaThomas E Lew, Adrian Minson, Michael Dickinson, et al.
Bone Marrow Transplantation|August 26, 2022
Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoidesJessica Elliott, Shalini Ahlawat, H Miles Prince, et al.
Open Forum Infectious Diseases|October 23, 2023
High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post-Autologous Stem Cell Transplant PeriodVictoria G Hall, Natalie R Saunders, Emily Klimevski, et al.
Leukemia & Lymphoma|August 26, 2016
Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvementKah-Lok Chan, Carrie van der Weyden, Christine Khoo, et al.
BMC Cancer|November 4, 2025
Protocol for Fit4Transplant: iterative optimisation of an exercise prehabilitation service for haematological cancer patients using phase II adaptive trials and co-designCamille E Short, Lara Edbrooke, Shaza Abo, et al.
Haematologica|August 21, 2020
Clonal independence of <i>JAK2</i> and <i>CALR</i> or <i>MPL</i> mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencingElla R Thompson, Tamia Nguyen, Yamuna Kankanige, et al.
Pageof 7